Trevi Therapeutics Stock Price History

TRVI Stock  USD 6.82  0.04  0.58%   
Below is the normalized historical share price chart for Trevi Therapeutics extending back to May 07, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Trevi Therapeutics stands at 6.82, as last reported on the 22nd of July, with the highest price reaching 6.98 and the lowest price hitting 6.71 during the day.
IPO Date
7th of May 2019
200 Day MA
4.8149
50 Day MA
6.28
Beta
0.532
 
Covid
If you're considering investing in Trevi Stock, it is important to understand the factors that can impact its price. Trevi Therapeutics appears to be somewhat reliable, given 3 months investment horizon. Trevi Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0561, which indicates the firm had a 0.0561 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Trevi Therapeutics, which you can use to evaluate the volatility of the company. Please review Trevi Therapeutics' Semi Deviation of 2.83, risk adjusted performance of 0.062, and Coefficient Of Variation of 1703.88 to confirm if our risk estimates are consistent with your expectations.
As of now, Trevi Therapeutics' Total Stockholder Equity is increasing as compared to previous years. The Trevi Therapeutics' current Common Stock Shares Outstanding is estimated to increase to about 106.1 M, while Common Stock Total Equity is projected to decrease to under 37 K. . As of now, Trevi Therapeutics' Price Book Value Ratio is increasing as compared to previous years. The Trevi Therapeutics' current Price To Book Ratio is estimated to increase to 4.39, while Price Earnings Ratio is forecasted to increase to (8.25). Trevi Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0561

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsTRVI
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.56
  actual daily
31
69% of assets are more volatile

Expected Return

 0.2
  actual daily
4
96% of assets have higher returns

Risk-Adjusted Return

 0.06
  actual daily
4
96% of assets perform better
Based on monthly moving average Trevi Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Trevi Therapeutics by adding it to a well-diversified portfolio.
Price Book
8.398
Book Value
0.996
Enterprise Value
732.9 M
Enterprise Value Ebitda
(4.92)
Shares Float
82.4 M

Trevi Therapeutics Stock Price History Chart

There are several ways to analyze Trevi Stock price data. The simplest method is using a basic Trevi candlestick price chart, which shows Trevi Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJune 6, 20257.06
Lowest PriceJune 30, 20255.47

Trevi Therapeutics July 22, 2025 Stock Price Synopsis

Various analyses of Trevi Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Trevi Stock. It can be used to describe the percentage change in the price of Trevi Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Trevi Stock.
Trevi Therapeutics Accumulation Distribution 43,684 
Trevi Therapeutics Price Action Indicator(0.04)
Trevi Therapeutics Price Rate Of Daily Change 0.99 
Trevi Therapeutics Price Daily Balance Of Power(0.15)

Trevi Therapeutics July 22, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Trevi Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Trevi Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Trevi Stock and then apply it to test your longer-term investment strategies against Trevi.

Trevi Stock Price History Data

The price series of Trevi Therapeutics for the period between Wed, Apr 23, 2025 and Tue, Jul 22, 2025 has a statistical range of 1.59 with a coefficient of variation of 6.01. The price distribution for the period has arithmetic mean of 6.33. The median price for the last 90 days is 6.32.
OpenHighLowCloseVolume
07/21/2025 6.85  6.98  6.71  6.82  1,129,319 
07/18/2025
 6.92  7.19  6.80  6.86  2,262,407 
07/17/2025
 6.71  7.03  6.69  6.84  1,575,761 
07/16/2025 6.86  6.93  6.61  6.71  2,558,645 
07/15/2025
 7.03  7.05  6.80  6.86  1,584,704 
07/14/2025
 6.57  7.03  6.50  7.01  1,710,033 
07/11/2025
 6.40  6.60  6.25  6.55  1,442,154 
07/10/2025
 6.14  6.42  6.03  6.41  1,585,836 
07/09/2025
 5.97  6.34  5.93  6.17  1,595,085 
07/08/2025
 5.94  6.09  5.79  5.86  1,281,498 
07/07/2025
 5.90  6.07  5.78  5.95  1,316,534 
07/03/2025 5.98  6.00  5.71  5.95  993,025 
07/02/2025
 5.69  6.08  5.53  5.98  2,843,794 
07/01/2025 5.61  5.82  5.47  5.70  2,400,462 
06/30/2025
 5.59  5.66  5.41  5.47  1,499,109 
06/27/2025
 5.64  5.71  5.50  5.62  2,232,823 
06/26/2025
 5.67  5.71  5.55  5.66  971,186 
06/25/2025
 5.78  5.78  5.53  5.68  690,632 
06/24/2025
 5.77  5.96  5.60  5.77  1,110,860 
06/23/2025
 5.90  5.95  5.66  5.75  1,207,306 
06/20/2025 6.09  6.19  5.85  5.96  3,293,869 
06/18/2025
 6.12  6.24  5.98  6.07  1,432,300 
06/17/2025
 6.26  6.49  6.08  6.12  1,715,465 
06/16/2025
 6.10  6.36  6.07  6.34  1,231,895 
06/13/2025 6.10  6.34  6.05  6.09  1,142,084 
06/12/2025
 6.22  6.32  6.11  6.17  2,963,417 
06/11/2025 6.54  6.58  6.17  6.25  1,394,604 
06/10/2025
 6.44  6.57  6.26  6.51  1,362,722 
06/09/2025
 7.11  7.12  6.35  6.41  2,580,180 
06/06/2025
 6.85  7.10  6.76  7.06  2,489,465 
06/05/2025 6.54  6.90  6.35  6.74  3,045,261 
06/04/2025 6.20  6.59  6.02  6.58  9,058,188 
06/03/2025
 6.21  6.24  5.38  5.95  4,465,114 
06/02/2025 6.94  7.48  5.70  6.32  8,678,116 
05/30/2025 6.35  6.60  6.20  6.51  1,449,283 
05/29/2025 6.26  6.38  6.09  6.36  821,828 
05/28/2025
 6.33  6.39  6.08  6.26  871,259 
05/27/2025 6.34  6.47  6.10  6.16  1,251,702 
05/23/2025
 6.00  6.31  5.86  6.29  1,230,994 
05/22/2025
 6.16  6.19  6.02  6.03  671,112 
05/21/2025
 6.40  6.47  6.06  6.18  985,270 
05/20/2025
 6.56  6.64  6.43  6.47  999,579 
05/19/2025
 6.40  6.51  6.35  6.49  773,061 
05/16/2025
 6.19  6.70  6.19  6.50  1,652,371 
05/15/2025
 6.21  6.33  6.12  6.19  1,329,891 
05/14/2025
 6.49  6.78  6.19  6.19  892,672 
05/13/2025
 6.74  6.83  6.40  6.46  757,416 
05/12/2025
 6.61  6.83  6.55  6.70  1,214,834 
05/09/2025
 7.13  7.17  6.37  6.60  1,430,047 
05/08/2025 6.67  6.78  6.37  6.60  1,246,350 
05/07/2025
 6.59  6.78  6.50  6.66  673,497 
05/06/2025
 6.80  6.85  6.56  6.58  707,353 
05/05/2025
 6.98  7.16  6.69  6.90  720,025 
05/02/2025
 7.00  7.24  6.78  6.99  1,033,463 
05/01/2025
 6.87  7.16  6.73  6.90  1,827,242 
04/30/2025
 6.25  7.02  6.14  6.91  1,576,510 
04/29/2025
 6.54  6.74  6.29  6.31  3,809,142 
04/28/2025
 6.54  6.70  6.39  6.59  1,490,220 
04/25/2025
 6.31  6.49  6.13  6.47  1,149,945 
04/24/2025
 6.25  6.38  6.18  6.35  882,714 
04/23/2025
 6.21  6.45  6.01  6.27  1,226,815 

About Trevi Therapeutics Stock history

Trevi Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Trevi is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Trevi Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Trevi Therapeutics stock prices may prove useful in developing a viable investing in Trevi Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding101 M106.1 M
Net Loss-26.2 M-27.5 M

Trevi Therapeutics Quarterly Net Working Capital

98.75 Million

Trevi Therapeutics Stock Technical Analysis

Trevi Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Trevi Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Trevi Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module

Trevi Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Trevi Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Trevi Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Trevi to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Trevi Stock analysis

When running Trevi Therapeutics' price analysis, check to measure Trevi Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trevi Therapeutics is operating at the current time. Most of Trevi Therapeutics' value examination focuses on studying past and present price action to predict the probability of Trevi Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trevi Therapeutics' price. Additionally, you may evaluate how the addition of Trevi Therapeutics to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance